Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

- Tocchetti, Carlo Gabriele, Farmakis, Dimitrios, Plummer, Chris, Gulati, Geeta, Ramalingam, Sivatharshini, Cardinale, Daniela, Brezden-Masley, Christine, Iakobishvili, Zaza, Thavendiranathan, Paaladinesh, Santoro, Ciro, Bergler-Klein, Jutta, Keramida, Kalliopi, Koop, Yvonne, de Boer, Rudolf A., Maack, C, Lutgens, E, Rassaf, T, Fradley, MG, Moslehi, J, Yang, EH, De Keulenaer, G, Ameri, P, Bax, J, Andres, Maria Sol, Neilan, TG, Herrmann, J, Mbakwem, AC, Mirabel, M, Skouri, H, Hirsch, E, Cohen-Solal, A, Sverdlov, Aaron L., van der Meer, P, Asteggiano, R, Couch, Liam S., Barac, A, Ky, B, Lenihan, D, Dent, S, Seferovic, P, Coats, AJS, Metra, M, Rosano, G, Suter, T, Lopez-Fernandez, T, Formisano, Luigi, Lyon, AR, Ciardiello, Fortunato, Pane, Fabrizio, Au, Lewis, Emmerich, Max

European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment

- Lee, G. A., Aktaa, S., Jurczak, W., Lopez, P. Garrido, Sverdlov, A. L., Tocchetti, C. G., Barac, A., Parrini, I., Zamorano, P., Iakobishvili, Z., Pudil, R., Badimon, L., Baker, E., Kirby, A. M., Blaes, AH, Farmakis, D, Curigliano, G, Stephens, R, Lyon, AR, Lopez-Fernandez, T, Gale, C. P., Yaseen, Israa F., Gulati, G., Asteggiano, R., Szmit, S., Cohen-Solal, A., Abdin, A.